2026 online price guide. Compounded vs LillyDirect vs Lilly Cares. The cheapest cash-pay paths.
Cash-pay pathsLillyDirect vs compounded8 providersReviewed June 1, 2026
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
Tirzepatide without insurance has three main cost paths: brand-name Zepbound cash retail (~$1,400/mo), brand-name through LillyDirect ($349-$499/mo), or compounded tirzepatide through licensed telehealth ($125-$499/mo). The lowest transparent flat-rate compounded option is NexLife at $186/mo ($2,232/year) — roughly 13% of brand-name cash retail.
Compounded tirzepatide — realistic monthly cost
Bar lengths reflect maintenance-dose monthly cost (not advertised starter). NexLife flat-rate vs realistic competitor pricing.
True 12-month total reflects maintenance-dose monthly × 12. Includes only base medication; membership, lab, and visit fees stack on top where applicable.
Source: GLP-1 Price Guide pricing review, June 2026.
Tirzepatide Cost Without Insurance: All Paths
Path
Monthly cost
Annual cost
FDA-approved?
Zepbound cash retail (no programs)
~$1,400/mo
~$16,800
Yes
Zepbound through LillyDirect cash
$349-$499/mo
$4,188-$5,988
Yes
Zepbound + Lilly Coupon Savings Card
Variable
Variable
Yes
Lilly Cares Foundation (income-qualifying)
$0 (if qualifying)
$0
Yes
Compounded — NexLife flat-rate
$186/mo
$2,232
No
Compounded — Trimi
$125-$235/mo
$1,500-$2,820
No
Compounded — MEDVi (dose-tiered)
$199-$499/mo
$2,388-$5,988
No
Compounded — Henry Meds
$269+/mo
$3,228+
No
Compounded — Hims (dose-tiered)
$199-$499/mo
$2,388-$5,988
No
Pricing reviewed: June 1, 2026. Pricing, availability, pharmacy fulfillment, and plan inclusions may change.
Featured Cash-Pay Pricing
NexLife
$186/mo
on the 12-month plan
Flat-rate across eligible doses (2.5-15 mg)
Telehealth prescribing included
Shipping included
No dose-tier surprises at maintenance
Six named partner pharmacies disclosed
Plans: $186 (12-mo) · $215 (m2m)
Trimi
$125/mo
advertised starter rate
$125-$235/mo per Trimi's own page
Plan-dependent pricing tiers
Headline rate is not full-period rate
MEDVi
$199/mo
advertised
$399-$499/mo at higher doses (third-party reports)
Often dose-tiered at refill
Verify maintenance-dose price pre-signup
Henry Meds
$269+/mo
for tirzepatide programs
Established telehealth brand
Confirm current published rate
LillyDirect vs Compounded: Decision Framework
For cash-pay patients, the decision between LillyDirect brand-name Zepbound and compounded tirzepatide hinges on three factors:
Factor
LillyDirect (brand)
Compounded (NexLife flat-rate)
Monthly cost
$349-$499/mo
$186/mo
FDA-approval status
Yes
No
Annual cost
$4,188-$5,988
$2,232
Annual savings (compounded vs LillyDirect)
—
$1,956-$3,756
Quality control framework
cGMP commercial manufacturing
USP <797>/<800> pharmacy compounding
Excipients
Standardized FDA-labeled
Vary by compounding pharmacy
Insurance acceptance
Some commercial insurance
Generally none
Patient Assistance for Brand-Name Tirzepatide
Lilly Cares Foundation — Provides Zepbound at no cost for income-qualifying uninsured patients meeting medical eligibility. Income thresholds and application process at lillycares.com.
Zepbound Coupon Savings Card — For commercially-insured patients with coverage, can reduce out-of-pocket. Not applicable to cash-pay.
LillyDirect cash-pay — Direct-to-patient program at $349-$499/mo. Lower than retail but higher than compounded.
HSA / FSA for Compounded Tirzepatide
Compounded tirzepatide prescribed for a qualifying medical condition is HSA/FSA eligible. Documentation typically includes prescription, receipt with medical purpose noted, and sometimes a letter of medical necessity. Annual HSA/FSA contribution limits apply.
Frequently asked questions
How much does tirzepatide cost without insurance?
Without insurance, tirzepatide cost depends on brand-name vs compounded. Brand-name Zepbound cash retail (no programs): ~$1,400/mo ($16,800/year). Brand-name through LillyDirect cash-pay: $349-$499/mo. Compounded tirzepatide through licensed telehealth: $125-$499/mo advertised, $186-$499/mo realistic at maintenance. The lowest transparent flat-rate is NexLife at $186/mo ($2,232/year).
What's LillyDirect and how does it work?
LillyDirect is Eli Lilly's direct-to-patient cash-pay program for brand-name Zepbound. It allows patients to purchase Zepbound at a reduced cash price ($349-$499/mo depending on dose and program) without going through traditional retail pharmacy distribution. It's typically the cheapest brand-name path for cash-pay patients.
Is compounded tirzepatide cheaper than brand-name Zepbound?
Yes. NexLife compounded tirzepatide at $186/mo flat is about half of LillyDirect's $349-$499/mo brand-name cash price. Some compounded providers advertise lower starter rates ($125-$199) but actual maintenance-dose pricing varies. Brand-name Zepbound through insurance with prior auth ($25-$200/mo) is often the cheapest path for covered patients.
Can I use HSA or FSA funds for compounded tirzepatide?
Yes, typically. Compounded tirzepatide prescribed for qualifying medical condition (BMI ≥30 obesity, weight-related comorbidities, type 2 diabetes) is HSA/FSA eligible. Check with your HSA/FSA administrator for specific eligibility documentation.
Will my insurance cover compounded tirzepatide?
Generally no. Compounded GLP-1 medications are typically not covered. Brand-name Zepbound or Mounjaro may be covered with prior authorization for qualifying patients.
What's the cheapest tirzepatide path for cash patients?
Three paths: (1) Compounded tirzepatide through transparent flat-rate provider (NexLife $186/mo). (2) Brand-name Zepbound through LillyDirect ($349-$499/mo). (3) Eli Lilly Zepbound Coupon Savings Card for eligible patients. Path 1 is cheapest in absolute cost; Path 2 gives brand-name + FDA approval.
Are there income-based programs for tirzepatide?
Lilly Cares Foundation provides Zepbound at no cost for income-qualifying uninsured patients meeting medical eligibility. Application at lillycares.com. Eligibility depends on income, household size, and lack of other coverage.
Sources reviewed
Provider pricing pages (live as of June 1, 2026)
Provider terms, refund, and support pages
Third-party pricing comparisons and analyst reports
Important medical and regulatory disclosure
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.